review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Giovanni Scapagnini | Q56814243 |
Sergio Davinelli | Q56934618 | ||
Renata Bracale | Q57328719 | ||
P2093 | author name string | Davide Zella | |
Nadia Sapere | |||
Mariano Intrieri | |||
P2860 | cites work | Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. | Q50688366 |
Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro. | Q51930765 | ||
Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. | Q53204876 | ||
Biomarkers: warning signs. | Q53213626 | ||
Rapid induction of Alzheimer A beta amyloid formation by zinc. | Q53316140 | ||
Iron chelation in the biological activity of curcumin. | Q55041704 | ||
Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress | Q61837710 | ||
Nitric oxide scavenging by curcuminoids | Q73272444 | ||
The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B | Q73305343 | ||
Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells | Q74080109 | ||
Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa | Q74256041 | ||
Inflammatory processes in Alzheimer's disease | Q79557863 | ||
Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies | Q84099656 | ||
Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity | Q84627293 | ||
Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease | Q24305330 | ||
Resveratrol improves health and survival of mice on a high-calorie diet | Q27860950 | ||
Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia | Q28222555 | ||
Sirtuin activators | Q28244893 | ||
Flavonoids: modulators of brain function? | Q28281453 | ||
Pharmacology of Curcuma longa | Q28328461 | ||
Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin | Q28477422 | ||
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis | Q28583941 | ||
Therapeutic potential of resveratrol: the in vivo evidence | Q29547413 | ||
Electron transport chain defects in Alzheimer's disease brain | Q48107929 | ||
Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution | Q48296640 | ||
Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats | Q48352370 | ||
Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | Q48446631 | ||
Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms | Q48480979 | ||
Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice | Q48493829 | ||
ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein | Q48577940 | ||
Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners | Q30397380 | ||
NMR study of the solution structure of curcumin | Q31102198 | ||
Curcumin activates defensive genes and protects neurons against oxidative stress | Q33242451 | ||
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease | Q33944063 | ||
The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. | Q33955271 | ||
Roles of molecular chaperones in the nervous system | Q34067828 | ||
Resveratrol differentially modulates inflammatory responses of microglia and astrocytes | Q34114119 | ||
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group | Q34443696 | ||
Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. | Q34450913 | ||
Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases | Q34480991 | ||
Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology | Q34520040 | ||
Curcumin: the story so far. | Q34559908 | ||
Modulation of Ca²⁺ signals by epigallocatechin-3-gallate(EGCG) in cultured rat hippocampal neurons | Q34578174 | ||
Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. | Q34579152 | ||
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice | Q34656230 | ||
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers | Q34656396 | ||
Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons | Q34772619 | ||
Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. | Q34844564 | ||
Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C | Q35046233 | ||
The "Alzheimer's disease signature": potential perspectives for novel biomarkers. | Q35339326 | ||
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases | Q35820578 | ||
Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression | Q35864100 | ||
SIRT1 and neuronal diseases | Q36775876 | ||
The redox chemistry of the Alzheimer's disease amyloid beta peptide. | Q36791163 | ||
Neuroprotective effects of curcumin | Q36849490 | ||
Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? | Q36949377 | ||
Recent advances in the investigation of curcuminoids | Q36957175 | ||
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications | Q36979669 | ||
Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. | Q37192480 | ||
Nutraceutical antioxidants as novel neuroprotective agents | Q37808095 | ||
Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders | Q37866170 | ||
Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element | Q38302521 | ||
Insights into the putative catechin and epicatechin transport across blood-brain barrier | Q39504007 | ||
Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction | Q39520490 | ||
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. | Q39722953 | ||
Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice | Q39748836 | ||
Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity | Q39832887 | ||
Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation. | Q40021673 | ||
The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate | Q40022059 | ||
Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells. | Q40068052 | ||
Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia | Q40078008 | ||
Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells | Q40099990 | ||
Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells | Q40281856 | ||
Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells | Q40633129 | ||
Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease | Q40635431 | ||
The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway | Q41185723 | ||
Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages | Q41380057 | ||
Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains | Q43062406 | ||
Severe motor neuron degeneration in the spinal cord of the Tg2576 mouse model of Alzheimer disease | Q43084838 | ||
Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease | Q43151191 | ||
Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation | Q43278469 | ||
Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action | Q44023075 | ||
Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher | Q44041028 | ||
Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability | Q44120619 | ||
Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes | Q44185416 | ||
(-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant | Q44225330 | ||
Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression | Q44270060 | ||
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells | Q44355279 | ||
Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate | Q44387375 | ||
Potential mechanism by which resveratrol, a red wine constituent, protects neurons | Q44508329 | ||
The neuroprotection of resveratrol in the experimental cerebral ischemia | Q44530331 | ||
Green tea catechins as a BACE1 (β-Secretase) inhibitor | Q44638638 | ||
Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice | Q44660671 | ||
Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro | Q44782704 | ||
Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells | Q44810239 | ||
Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. | Q45042828 | ||
Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure | Q45162337 | ||
Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. | Q45166299 | ||
Peroxynitrite interaction with curcumin solubilized in ethanolic solution | Q45217597 | ||
Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease | Q45223637 | ||
Gender differences in glutathione metabolism in Alzheimer's disease | Q45251935 | ||
EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism | Q45265258 | ||
Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. | Q45930606 | ||
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). | Q46070569 | ||
Epigallocatechin-3-gallate induced primary cultures of rat hippocampal neurons death linked to calcium overload and oxidative stress | Q46120065 | ||
Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models | Q46142687 | ||
Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by D-galactose | Q46175842 | ||
Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. | Q46253330 | ||
(-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency | Q46257745 | ||
Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells | Q46481176 | ||
Predicting how polyphenol antioxidants prevent DNA damage by binding to iron | Q46540481 | ||
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. | Q46715173 | ||
Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups | Q46916498 | ||
Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency | Q46940568 | ||
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. | Q47830583 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | Alzheimer's disease | Q11081 |
phytochemistry | Q640068 | ||
pleiotropy | Q1134884 | ||
neuroprotective agent | Q50377190 | ||
P304 | page(s) | 386527 | |
P577 | publication date | 2012-05-28 | |
P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
P1476 | title | Pleiotropic protective effects of phytochemicals in Alzheimer's disease | |
P478 | volume | 2012 |
Q48060692 | Antidepressant-Like Effect of Ropren® in β-Amyloid-(25-35) Rat Model of Alzheimer's Disease with Altered Levels of Androgens |
Q38658008 | Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. |
Q48949629 | Beneficial effects of an Andrographis paniculata extract and andrographolide on cognitive functions in streptozotocin-induced diabetic rats |
Q42701797 | Bisphenol-A Mediated Inhibition of Hippocampal Neurogenesis Attenuated by Curcumin via Canonical Wnt Pathway |
Q36891064 | Curcumin: a natural substance with potential efficacy in Alzheimer's disease |
Q47855717 | Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P450 genes in a mouse model |
Q26747783 | Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges |
Q60617431 | Different Conformation of Thiol Protease Inhibitor During Amyloid Formation: Inhibition by Curcumin and Quercetin |
Q38267471 | Epigenetic nutraceutical diets in Alzheimer's disease. |
Q40257007 | Family lifestyle and childhood obesity in an urban city of Northern Italy. |
Q36119633 | Improvement in Long-Term Memory following Chronic Administration of Eryngium planum Root Extract in Scopolamine Model: Behavioral and Molecular Study |
Q38085375 | Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. |
Q43590947 | Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice |
Q26824709 | Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications |
Q91781508 | Modifiable Risk Factors for Alzheimer's Disease |
Q64232099 | Modulating Effect of Diet on Alzheimer's Disease |
Q26750581 | Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview |
Q33785583 | Plant-based nutrition for healthcare professionals: implementing diet as a primary modality in the prevention and treatment of chronic disease |
Q35034790 | Plant-derived flavanol (-)epicatechin mitigates anxiety in association with elevated hippocampal monoamine and BDNF levels, but does not influence pattern separation in mice |
Q39204729 | Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds |
Q34535918 | Redox-based therapeutics in neurodegenerative disease |
Q55073180 | Resveratrol attenuates neurological deficit and neuroinflammation following intracerebral hemorrhage. |
Q36590615 | Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases |
Q26800947 | Role of Polyphenols and Other Phytochemicals on Molecular Signaling |
Q26859305 | Successful therapies for Alzheimer's disease: why so many in animal models and none in humans? |
Q27496021 | The Benefits and Risks of Consuming Brewed Tea: Beware of Toxic Element Contamination |
Q53084951 | The nutrient density approach to healthy eating: challenges and opportunities. |
Q37387226 | Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model |
Q90088394 | Zataria multiflora could improve hippocampal tau protein and TNFα levels and cognitive behavior defects in a rat model of Alzheimer's disease |
Search more.